← Back to Clinical Trials
Recruiting NCT06754150

NCT06754150 Shoulder Innovations Clinical Data Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06754150
Status Recruiting
Phase
Sponsor Shoulder Innovations
Condition Shoulder Arthroplasty
Study Type OBSERVATIONAL
Enrollment 2,500 participants
Start Date 2024-10-23
Primary Completion 2039-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,500 participants in total. It began in 2024-10-23 with a primary completion date of 2039-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

Eligibility Criteria

Inclusion Criteria: 1. At least 18 years of age. 2. Plan to receive or has received a shoulder arthroplasty surgical procedure, with a minimum of one implanted Shoulder Innovations (SI) device component and be willing and able to complete post-operative visits as long as at least one SI device component remains implanted. 3. Able to provide informed consent prior to enrollment in the study (unless a waiver has been obtained). 4. Agree to and be able to consistently answer the specified Patient Reported Outcome Measures (PROM) pre-operatively and at each of the post-operative visits without the use of a translator. 5. Willing and able to comply with the requirements of the study protocol Exclusion Criteria: 1. Participation in a clinical trial of an investigational drug or device that would confound the results of this trial. Participation in another observational registry is allowed provided there are no conflicting requirements to this trial. 2. Incarceration. 3. Any conditions, co-morbidities, restrictions, or obligations that would prohibit them from complying with the requirements of this study protocol.

Contact & Investigator

Central Contact

Alyson Harris

✉ alyson.harris@shoulderinnovations.com

📞 408-667-0535

Frequently Asked Questions

Who can join the NCT06754150 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06754150 currently recruiting?

Yes, NCT06754150 is actively recruiting participants. Contact the research team at alyson.harris@shoulderinnovations.com for enrollment information.

Where is the NCT06754150 trial being conducted?

This trial is being conducted at Birmingham, United States, Birmingham, United States, San Francisco, United States, Denver, United States and 4 additional locations.

Who is sponsoring the NCT06754150 clinical trial?

NCT06754150 is sponsored by Shoulder Innovations. The trial plans to enroll 2,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology